Glucose indices are associated with cognitive and structural brain measures in young adults

Neurology

Volumn 84, Issue 23, 2015, Pages 2329-2337

  Weinstein, Galit ^a,b   Maillard, Pauline ^c   Himali, Jayandra J ^a,b   Beiser, Alexa S ^a,b,d   Au, Rhoda ^a,b   Wolf, Philip A ^a,b   Seshadri, Sudha ^a,b   Decarli, Charles ^c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FRAMINGHAM HEART STUDY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; ATTENTION; BRAIN ATROPHY; BRAIN INJURY; BRAIN SIZE; COGNITION; DIET RESTRICTION; DIFFUSION TENSOR IMAGING; EXECUTIVE FUNCTION; FEMALE; FRACTIONAL ANISOTROPY; FRONTAL LOBE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GRAY MATTER; HIPPOCAMPUS; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; MEMORY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PARIETAL LOBE; PRIORITY JOURNAL; RECALL; TEMPORAL LOBE; VISION; VOXEL BASED MORPHOMETRY; WHITE MATTER; YOUNG ADULT; AGED; BLOOD; BRAIN DISEASES; COGNITION DISORDERS; DIABETES MELLITUS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; BLOOD GLUCOSE; BRAIN DISEASES; COGNITION DISORDERS; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; GRAY MATTER; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; WHITE MATTER; YOUNG ADULT;

EID: 84930688450     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001655     Document Type: Article

References (40)

1. Lu FP, Lin KP, Kuo HK. Diabetes and the risk of multisystem aging phenotypes: a systematic review and metaanalysis. PLoS One 2009;4:e4144.
2. Yaffe K, Falvey C, Hamilton N, et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 2012;69:1170-1175.
3. Qiu C, Sigurdsson S, Zhang Q, et al. Diabetes, markers of brain pathology, and cognitive cognition: the AGESReykjavik Study. Ann Neurol 2014;75:138-146.
4. Debette S, Seshadri S, Beiser A, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011;77:461-468.
5. Falvey CM, Rosano C, Simonsick EM, et al. Macro-and microstructural magnetic resonance imaging indices associated with diabetes among community-dwelling older adults. Diabetes Care 2013;36:677-682.
6. Kerti L, Witte AV, Winkler A, Grittner U, Rujescu D, Floel A. Higher glucose levels associated with lower memory and reduced hippocampal microstructure. Neurology 2013;81:1746-1752.
7. Barnett JH, Hachinski V, Blackwell AD. Cognitive health begins at conception: addressing dementia as a lifelong and preventable condition. BMC Med 2013;11:246.
8. Tolppanen AM, Solomon A, Soininen H, Kivipelto M. Midlife vascular risk factors and Alzheimer's disease: evidence from epidemiological studies. J Alzheimers Dis 2012;32:531-540.
9. Gold SM, Dziobek I, Sweat V, et al. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 2007;50:711-719.
10. Yau PL, Javier DC, Ryan CM, et al. Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia 2010;53:2298-2306.
11. Splansky GL, Corey D, Yang Q, et al. The third generation cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol 2007;165:1327-1335.
12. Maillard P, Seshadri S, Beiser A, et al. Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study. Lancet Neurol 2012;11:1039-1047.
13. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part I: clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
14. DeCarli C, Massaro J, Harvey D, et al. Measures of brain morphology and infarction in the Framingham Heart Study: establishing what is normal. Neurobiol Aging 2005;26:491-510.
15. Lee DY, Fletcher E, Martinez O, et al. Regional pattern of white matter microstructural changes in normal aging, MCI, and AD. Neurology 2009;73:1722-1728.
16. Kochunov P, Lancaster JL, Thompson P, et al. Regional spatial normalization: toward an optimal target. J Comput Assist Tomogr 2001;25:805-816.
17. Au R, Seshadri S, Wolf PA, et al. New norms for a new generation: cognitive performance in the Framingham offspring cohort. Exp Aging Res 2004;30:333-358.
18. Smith SM, Nichols TE. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009;44:83-98.
19. Zhang Y, Zhang J, Oishi K, et al. Atlas-guided tract reconstruction for automated and comprehensive examination of the white matter anatomy. Neuroimage 2010;52:1289-1301.
20. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008;40:879-891.
21. Venables WN, Ripley BD. Modern Applied Statistics with S, 4th ed. New York: Springer; 2002.
22. Ryan CM, Geckle M. Why is learning and memory dysfunction in type 2 diabetes limited to older adults? Diabetes Metab Res Rev 2000;16:308-315.
23. Biessels GJ, Deary IJ, Ryan CM. Cognition and diabetes: a lifespan perspective. Lancet Neurol 2008;7:184-190.
24. Ruis C, Biessels GJ, Gorter KJ, van den Donk M, Kappelle LJ, Rutten GE. Cognition in the early stage of type 2 diabetes. Diabetes Care 2009;32:1261-1265.
25. Tan ZS, Beiser AS, Fox CS, et al. Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study. Diabetes Care 2011;34:1766-1770.
26. King KS, Peshock RM, Rossetti HC, et al. Effect of normal aging versus hypertension, abnormal body mass index, and diabetes mellitus on white matter hyperintensity volume. Stroke 2014;45:255-257.
27. Carmichael O, Xie J, Fletcher E, Singh B, DeCarli C. Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume. Neurobiol Aging 2012;33:1124. e1131-1124.e1141.
28. Andrade-Moraes CH, Oliveira-Pinto AV, Castro-Fonseca E, et al. Cell number changes in Alzheimer's disease relate to dementia, not to plaques and tangles. Brain 2013;136: 3738-3752.
29. Lockhart SN, Mayda AB, Roach AE, et al. Episodic memory function is associated with multiple measures of white matter integrity in cognitive aging. Front Hum Neurosci 2012;6:56.
30. Thambisetty M, Jeffrey Metter E, Yang A, et al. Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging. JAMA Neurol 2013;70:1167-1172.
31. Talbot K, Wang HY, Kazi H, et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012;122:1316-1338.
32. Cholerton B, Baker LD, Craft S. Insulin resistance and pathological brain ageing. Diabet Med 2011;28: 1463-1475.
33. Arvanitakis Z, Wilson RS, Bennett DA. Diabetes mellitus, dementia, and cognitive function in older persons. J Nutr Health Aging 2006;10:287-291.
34. Srikanth V, Maczurek A, Phan T, et al. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. Neurobiol Aging 2011;32:763-777.
35. Whitmer RA. Type 2 diabetes and risk of cognitive impairment and dementia. Curr Neurol Neurosci Rep 2007;7:373-380.
36. Nir TM, Jahanshad N, Villalon-Reina JE, et al. Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging. Neuroimage Clin 2013;3:180-195.
37. Launer LJ, Miller ME, Williamson JD, et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol 2011; 10:969-977.
38. Meneilly GS, Cheung E, Tessier D, Yakura C, Tuokko H. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J Gerontol 1993; 48:M117-M121.
39. Gradman TJ, Laws A, Thompson LW, Reaven GM. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J Am Geriatr Soc 1993;41:1305-1312.
40. DeCarli C. Cerebrovascular disease: assessing the brain as an end-organ of vascular disease. Nat Rev Cardiol 2012;9: 435-436.